David Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are still too close. The research, by Geoffrey Spurling and colleagues, examined the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. David Henry's offers his Perspective in this week's PLoS Medicine Magazine.
Funding: The author received no specific funding for this article
Competing Interests: The author has declared that no competing interests exist.
Citation: Henry D (2010) Doctors and Drug Companies: Still Cozy after All These Years. PLoS Med 7(11):e1000359. doi:10.1371/journal.pmed.1000359
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000359
PRESS-ONLY PREVIEW OF THE ARTICLE: A preview of this article is not currently available. Please contact plosmedicine@plos.org if you wish to receive a copy.
CONTACT:
David Henry
Institute for Clinical Evaluative Sciences
Sunnybrook Health Sciences Centre
2075 bayview Avenue
Torono, Ontario M4N 3M5
Canada
14163716947
david.henry@ices.on.ca
PLOS Medicine